CTLA4 and neoplasm: Immune checkpoint surface receptors, such as programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), are expressed by tumor cells to avoid antitumor activity by T cells [88].